Comparing imeglimin vs. metformin for new type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial compares two diabetes pills, imeglimin and metformin, to see how they affect energy use in your cells. If you were recently diagnosed with type 2 diabetes and have not taken medication for it, this study might help find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were diagnosed with type 2 diabetes within the last year and have not taken any diabetes medication before (or stopped for at least 3 months).
- Your HbA1c (average blood sugar level) is between 6.5% and 7.5% at screening.
- Your kidney function is good enough (eGFR of 45 or higher).
- You do not have serious heart, liver, or other health conditions that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This trial compares two different combinations of diabetes pills (metformin plus empagliflozin with either sitagliptin or linagliptin) in people with type 2 diabetes who have not been treated before. It aims to see which combination works better and is safer for controlling blood sugar.
This trial compares two diabetes medications, empagliflozin and glimepiride, added to your current treatment to see which is more effective and safe for managing blood sugar. It is for adults with type 2 diabetes who have already been on oral diabetes pills for at least 8 weeks.
Hear when a new Mitochondria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.